Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates

Zeynep Yazgan; Gökhan Aygün; Nuri Kiraz; Zekayi Kutlubay

doi:10.30708/mantar.2005970

TR EN

Klinik Dermatofit İzolatlarının Tür Dağılımı, Tür Karakterizasyonu ve Antifungal Duyarlılığı

Abstract

Antifungal ilaçlara dirençli dermatofitlerin ortaya çıkması nedeniyle dermatofitozun küresel epidemiyolojisi hızla değişmektedir. Epidemiyolojik sürveyans, tedavi kararları ve dirençli suşların erken tespiti için tür düzeyinde doğru tanımlama ve klinik mikrobiyoloji laboratuvarları ile klinisyenler arasındaki etkileşimin gerekliliğini vurgulamıştır. Bu çalışma, rutin klinik uygulamada karşılaşılan dermatofit enfeksiyonlarının epidemiyolojik özelliklerini, anatomik dağılımını ve antifungal duyarlılık profillerini değerlendirmeyi ve ayrıca MALDI-TOF MS ile geleneksel mikolojik yöntemlerin rutin klinik uygulamadaki tamamlayıcı rollerini araştırmayı amaçlamıştır. İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi Hastanesi Tıbbi Mikrobiyoloji ve Mikoloji Laboratuvarı'nda, 2017-2018 yılları arasında yüzeysel mikozların klinik örneklerinden elde edilen 126 dermatofit izolatı, konvansiyonel ve MALDI-TOF yöntemleri kullanılarak analiz edildi. Tekrarlayan enfeksiyonları olan hastalara antifungal duyarlılık testi uygulandı. En sık görülen klinik tablo, vakaların %41,3'ünü oluşturan tinea corporis (vücut mantarı), ardından %30,2 ile tinea unguium (tırnak mantarı) ve %11,9 ile tinea pedis (ayak mantarı) idi. MALDI-TOF MS, 126 izolatın 71'i (%56,3) için tür düzeyinde güvenilir tanımlama sağlarken, geri kalan 55 izolat (%43,7) geleneksel mikolojik yöntemler kullanılarak karakterize edildi. Konvansiyonel yöntemlerle 39 izolatın Trichophyton mentagrophytes, dördünün Microsporum canis, üçünün Trichophyton rubrum, iki tanesinin Trichophyton tonsurans, bir tanesinin Microsporum audouinii ve bir tanesinin Trichophyton violaceum olduğu, beş izolatın ise diğer dermatofit türleri olduğu bildirildi. Genel olarak T. rubrum en sık izole edilen tür (%48,4) olurken, bunu T. mentagrophytes (%31,7) izledi. Antifungal duyarlılık testleri, kalıcı veya tekrarlayan vakalardan elde edilen izolatlar arasında değişken duyarlılık profilleri gösterdi. Dermatofitlerin tanımlanmasında MALDI-TOF MS ve geleneksel fenotipik yöntemler birbirini tamamlayıcı yaklaşımlar olarak değerlendirilmelidir. Tür tanımlamasına geleneksel yöntemlerin önemli katkısı, özellikle ticari MALDI-TOF MS veritabanlarının eksik olduğu durumlarda, bu yöntemlerin rutin klinik mikoloji laboratuvarlarındaki devam eden öneminin altını çizmektedir. Tanımlama ve duyarlılık testinin entegre edilmesi, dirençli dermatofitozun yönetimini ve izlenmesini geliştirir.

Keywords

Supporting Institution

İSTANBUL ÜNİVERSİTESİ-CERRAHPAŞA REKTÖRLÜĞÜ Klinik Araştırmalar Etik Kurulu

Project Number

Decision number: 2024-992631; Annex 1

Ethical Statement

Anabilim Dalınızda görevli Biyolog Zeynep YAZGAN'ın yürütücülüğünde, Prof.Dr.Gökhan AYGÜN'ün danışmanlığında yapılacak olan ''Klinik Örneklerden Üretilen Küf İzolatlarının Tanımında MALDI-TOF MS Kullanımı'' başlıklı çalışma 14.05.2024 tarihli etik kurulumuzca müzakere edilmiş olup, etik açıdan uygun görülmüştür.

Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates

Abstract

The global epidemiology of dermatophytosis is rapidly changing due to the emergence of antifungal-resistant dermatophytes. Epidemiological surveillance has highlighted the need for accurate species-level identification and interaction between clinical microbiology laboratories and clinicians for treatment decisions and early detection of resistant strains. This study evaluated the epidemiological characteristics, anatomical distribution, and antifungal susceptibility profiles of dermatophyte infections encountered in routine clinical practice, and also aimed to investigate the complementary roles of MALDI-TOF MS and traditional mycological methods in routine clinical practice. In the Medical Microbiology and Mycology Laboratory of Istanbul University-Cerrahpaşa Faculty of Medicine Hospital, 126 dermatophyte isolates obtained from clinical samples of superficial mycoses between 2017-2018 were analyzed using conventional and MALDI-TOF methods. Patients with recurrent infections underwent antifungal susceptibility testing. Tinea corporis was the predominant clinical presentation, accounting for 41.3% of cases, followed by tinea unguium (30.2%) and tinea pedis (11.9%). MALDI-TOF MS provided reliable species-level identification for 71 (56.3%) of 126 isolates, while the remaining 55 isolates (43.7%) were characterized using conventional mycological methods. Conventional methods identified 39 isolates as Trichophyton mentagrophytes, four as Microsporum canis, three as Trichophyton rubrum, two as Trichophyton tonsurans, one as Microsporum audouinii, and one as Trichophyton violaceum, while five isolates were reported as other dermatophyte species. Overall, T. rubrum was the most frequently isolated species (48.4%), followed by T. mentagrophytes (31.7%). Antifungal susceptibility testing showed variable susceptibility profiles among isolates from persistent or recurrent cases. MALDI-TOF MS and conventional phenotypic methods should be considered complementary approaches for dermatophyte identification. The significant contribution of conventional methods to species identification underscores their continued importance in routine clinical mycology laboratories, particularly in situations where commercial MALDI-TOF MS databases are incomplete. Integrating identification and susceptibility testing improves the management and monitoring of resistant dermatophytosis.

Keywords

Supporting Institution

Istanbul University-Cerrahpaşa Rectorate Clinical Research Ethics Committee

Project Number

Decision number: 2024-992631; Annex 1

Thanks

The study entitled "Use of MALDI-TOF MS in the Identification of Mold Isolates Produced from Clinical Samples," to be conducted under the supervision of Biologist Zeynep YAZGAN, affiliated with your department, and with Prof. Dr. Gökhan AYGÜN as advisor, was discussed by our ethics committee on May 14, 2024, and found to be ethically appropriate.

References

Cassagne, C., Normand, A. C., L'Ollivier, C., Ranque, S., & Piarroux, R. (2016). Performance of MALDI-TOF MS platforms for fungal identification. Mycoses, 59(11), 678–690. https://doi.org/10.1111/myc.12506
de Hoog, G. S., Dukik, K., Monod, M., Packeu, A., Stubbe, D., Hendrickx, M., Kupsch, C., Stielow, J. B., Freeke, J., Göker, M., Rezaei-Matehkolaei, A., Mirhendi, H., Gräser, Y., & Summerbell, R. C. (2017). Toward a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia, 182(1–2), 5–31. https://doi.org/10.1007/s11046-016-0073-9
de Hoog, G. S., Monod, M., Dawson, T., Guillot, J., Gräser, Y., & Summerbell, R. (2019). Skin fungi and skin diseases: Dermatophytes, Malassezia, and related organisms. In J. Heitman, B. J. Howlett, P. W. Crous, E. H. Stukenbrock, T. Y. James, & N. A. R. Gow (Eds.), The Fungal Kingdom (pp. 901–920). ASM Press. https://doi.org/10.1128/9781555819583.ch44
de Respinis, S., Monnin, V., Girard, V., Welker, M., Arsac, M., Cellière, B., Durand, G., Farina, C., Passera, M., Van Belkum, A., Petrini, O., Tonolla, M., & Bosshard, P. P. (2014). Matrix-assisted laser desorption ionization–time of flight mass spectrometry using the Vitek MS system for rapid and accurate identification of dermatophytes on solid cultures. Journal of Clinical Microbiology, 52(12), 4286–4292. https://doi.org/10.1128/JCM.02199-14
Ebert, A., Monod, M., Salamin, K., Burmester, A., Uhrlaß, S., Wiegand, C., Hipler, U. C., Krüger, C., Koch, D., & Nenoff, P. (2023). Alarming India-wide phenomenon of antifungal resistance in dermatophytes: A multidisciplinary review. Journal of Fungi, 9(1), 30. https://doi.org/10.3390/jof9010030
European Committee on Antimicrobial Susceptibility Testing. (2024). Definitive document E.Def 11.0: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds and dermatophytes. EUCAST. https://www.eucast.org
European Committee on Antimicrobial Susceptibility Testing. (2025). Overview of antifungal ECOFFs and clinical breakpoints for yeasts, moulds and dermatophytes, version 6.0. EUCAST. https://www.eucast.org
Gupta, A. K., Mann, A., Ravi, S. P., & Wang, T. (2024a). An update on antifungal resistance in dermatophytosis. Expert Opinion on Pharmacotherapy, 25(5), 511–519. https://doi.org/10.1080/14656566.2024.2343079

Gupta, A. K., Wang, T., Mann, A., Ravi, S. P., Talukder, M., Lincoln, S. A., Foreman, H. C., Kaplan, B., Galili, E., Piguet, V., Shemer, A., & Bakotic, W. L. (2024b). Antifungal resistance in dermatophytes: Review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae infections. Expert Review of Anti-Infective Therapy, 22(9), 739–751. https://doi.org/10.1080/14787210.2024.2390629
Jabet, A., Brun, S., Normand, A.-C., Imbert, S., Akhoundi, M., Dannaoui, E., Audiffred, L., Chasset, F., Izri, A., Laroche, L., Piarroux, R., Bachmeyer, C., Hennequin, C., & Moreno Sabater, A. (2022). Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae, France. Emerging Infectious Diseases, 28(1), 229–233. https://doi.org/10.3201/eid2801.210883
Kano, R., Kimura, U., Kakurai, M., Hiruma, J., Kamata, H., Suga, Y., & Hiruma, M. (2020). Trichophyton indotineae sp. nov.: A new highly terbinafine-resistant anthropophilic dermatophyte species. Mycopathologia, 185(6), 947–958. https://doi.org/10.1007/s11046-020-00455-8
Khan, S. S., Hay, R. J., & Saunte, D. M. L. (2022). A review of antifungal susceptibility testing for dermatophyte fungi and its correlation with previous exposure and clinical responses. Journal of Fungi, 8(12), Article 1290. https://doi.org/10.3390/jof8121290
Khurana, A., Masih, A., Chowdhary, A., Sardana, K., & Borker, S. (2019). Correlation of in vitro susceptibility based on MICs and SQLE mutations with clinical response to terbinafine in patients with tinea corporis/cruris. Antimicrobial Agents and Chemotherapy, 62(12), e01038-18. https://doi.org/10.1128/AAC.01038-18
Kidd, S., Halliday, C., & Ellis, D. (2023). Descriptions of medical fungi (4th ed.). CABI. https://doi.org/10.1079/9781800622326.0000
Lau, A. F., Walchak, R. C., & Miller, H. B. (2019). Development and clinical application of MALDI-TOF mass spectrometry for the identification of filamentous fungi. Mycoses, 62(9), 837–847. https://doi.org/10.1111/myc.12952
Nenoff, P., Verma, S. B., Vasani, R., Burmester, A., Hipler, U. C., Wittig, F., Krüger, C., Koch, D., & Ebert, A. (2021). The current Indian epidemic of superficial dermatophytosis due to Trichophyton indotineae: A molecular study and review. Mycoses, 64(10), 1184–1203. https://doi.org/10.1111/myc.13301
Nenoff, P., Uhrlaß, S., Krüger, C., Schaller, J., & Ebert, A. (2023). Dermatophytoses and changing spectrum of dermatophytes: New epidemiological and diagnostic challenges. Journal of Fungi, 9(5), 575. https://doi.org/10.3390/jof9050575
Normand, A. C., Cassagne, C., Gautier, M., Becker, P., Ranque, S., Hendrickx, M., & Piarroux, R. (2017). Decision criteria for MALDI-TOF MS-based identification of filamentous fungi using commercial and in-house reference databases. BMC Microbiology, 17, 25. https://doi.org/10.1186/s12866-017-0937-2
Oğuz, İ. D., Direkel, Ş., Akşan, B., Kulaklı, S., & Aksoy, S. (2024). In vitro antifungal susceptibility of the dermatophytes: A single-center study from the Eastern Black Sea Region of Türkiye. European Review for Medical and Pharmacological Sciences, 28(6), 2144–2154. https://doi.org/10.26355/eurrev_202403_35717
Packeu, A., De Bel, A., l'Ollivier, C., Ranque, S., Detandt, M., & Hendrickx, M. (2014). Fast and accurate identification of dermatophytes by matrix-assisted laser desorption ionization–time of flight mass spectrometry: Validation in the clinical laboratory. Journal of Clinical Microbiology, 52(9), 3440–3443. https://doi.org/10.1128/JCM.01428-14
Patel, R. (2019). A moldy application of MALDI: MALDI-ToF mass spectrometry for fungal identification. Journal of Fungi, 5(1), 4. https://doi.org/10.3390/jof5010004
Rychert, J., Burnham, C.-A. D., Bythrow, M., Garner, O. B., Ginocchio, C. C., Jennemann, R., Lewinski, M., Manji, R., Mochon, A., Procop, G. W., Richter, S. S., & Westblade, L. F. (2018). Evaluation of the VITEK MS v3.0 system for the identification of clinically relevant dermatophytes. Journal of Clinical Microbiology, 56(10), e00838-18. https://doi.org/10.1128/JCM.00838-18
Sesli, E., Asan, A. ve Selçuk, F. (edlr.) Abacı Günyar, Ö., Akata, I., Akgül, H., Aktaş, S., Alkan, S., Allı, H., Aydoğdu, H., Berikten, D., Demirel, K., Demirel, R., Doğan, H.H., Erdoğdu, M., Ergül, C.C., Eroğlu, G., Giray, G., Halikî Uztan, A., Kabaktepe, Ş., Kadaifçiler, D., Kalyoncu, F., Karaltı, İ., Kaşık, G., Kaya, A., Keleş, A., Kırbağ, S., Kıvanç, M., Ocak, İ., Ökten, S., Özkale, E., Öztürk, C., Sevindik, M., Şen, B., Şen, İ., Türkekul, İ., Ulukapı, M., Uzun, Ya., Uzun, Yu.,Yoltaş, A. (2020). Türkiye Mantarları Listesi. İstanbul: Ali Nihat Gökyiğit Vakfı Yayınları. Syf 1177.
Singh, A., Masih, A., Monroy-Nieto, J., Singh, P. K., Bowers, J., Travis, J., Khurana, A., Singh, A., Sharma, S., Meis, J. F., Chowdhary, A., & Gräser, Y. (2021). A unique multidrug-resistant clonal Trichophyton population distinct from the Trichophyton mentagrophytes/T. interdigitale species complex causing recalcitrant dermatophytosis in India. mBio, 12(5), e02581-21. https://doi.org/10.1128/mBio.02581-21
Taghipour, S., Pchelin, I. M., Zarei Mahmoudabadi, A., Ansari, S., Katiraee, F., Rafiei, A., Shokohi, T., Abastabar, M., Youssefi, M., Haghani, I., Nouripour-Sisakht, S., Makimura, K., de Hoog, G. S., Gräser, Y., & Rezaei-Matehkolaei, A. (2020). Trichophyton mentagrophytes and T. interdigitale genotypes are associated with different geographical distributions and antifungal susceptibility profiles. Medical Mycology, 58(7), 1058–1065. https://doi.org/10.1093/mmy/myaa012
Westblade, L. F., Burd, E. M., Lockhart, S. R., & Procop, G. W. (2023). Larone's medically important fungi: A guide to identification (7th ed.). John Wiley & Sons. https://doi.org/10.1002/9781683674436
World Health Organization. (2022). WHO fungal priority pathogens list to guide research, development and public health action. World Health Organization. https://www.who.int/publications/i/item/9789240060241
Yazgan, Z., & Aygün, G. (2026). Evaluation of MALDI-TOF MS for identification of clinical filamentous fungi in a routine mycology laboratory

Details

Primary Language

English

Subjects

Medical Mycology

Journal Section

Research Article

Authors

Zeynep Yazgan ^*
0000-0003-4354-3729
Türkiye

Gökhan Aygün
0000-0001-6915-9843
Türkiye

Nuri Kiraz
0000-0001-7415-190X
Türkiye

Zekayi Kutlubay
0000-0003-0809-1624
Türkiye

Publication Date

October 22, 2026

Submission Date

July 29, 2026

Acceptance Date

September 14, 2026

Published in Issue

Year 2026 Volume: 17 Number: 2

DOI

https://doi.org/10.30708/mantar.2005970

IZ

https://izlik.org/JA43SF87PK

Cite

RIS / Bibtex

APA

Yazgan, Z., Aygün, G., Kiraz, N., & Kutlubay, Z. (2026). Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates. Mantar Dergisi, 17(2), 174-184. https://doi.org/10.30708/mantar.2005970

AMA

1.Yazgan Z, Aygün G, Kiraz N, Kutlubay Z. Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates. Mantar Dergisi. 2026;17(2):174-184. doi:10.30708/mantar.2005970

Chicago

Yazgan, Zeynep, Gökhan Aygün, Nuri Kiraz, and Zekayi Kutlubay. 2026. “Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates”. Mantar Dergisi 17 (2): 174-84. https://doi.org/10.30708/mantar.2005970.

EndNote

Yazgan Z, Aygün G, Kiraz N, Kutlubay Z (October 1, 2026) Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates. Mantar Dergisi 17 2 174–184.

IEEE

[1]Z. Yazgan, G. Aygün, N. Kiraz, and Z. Kutlubay, “Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates”, Mantar Dergisi, vol. 17, no. 2, pp. 174–184, Oct. 2026, doi: 10.30708/mantar.2005970.

ISNAD

Yazgan, Zeynep - Aygün, Gökhan - Kiraz, Nuri - Kutlubay, Zekayi. “Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates”. Mantar Dergisi 17/2 (October 1, 2026): 174-184. https://doi.org/10.30708/mantar.2005970.

JAMA

1.Yazgan Z, Aygün G, Kiraz N, Kutlubay Z. Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates. Mantar Dergisi. 2026;17:174–184.

MLA

Yazgan, Zeynep, et al. “Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates”. Mantar Dergisi, vol. 17, no. 2, Oct. 2026, pp. 174-8, doi:10.30708/mantar.2005970.

Vancouver

1.Zeynep Yazgan, Gökhan Aygün, Nuri Kiraz, Zekayi Kutlubay. Species Distribution, Species Characterization, and Antifungal Susceptibility of Clinical Dermatophyte Isolates. Mantar Dergisi. 2026 Oct. 1;17(2):174-8. doi:10.30708/mantar.2005970